{"id":1042,"date":"2015-01-18T19:51:40","date_gmt":"2015-01-18T18:51:40","guid":{"rendered":"http:\/\/www.smhp.fr\/?page_id=1042"},"modified":"2015-07-26T14:43:21","modified_gmt":"2015-07-26T13:43:21","slug":"jfm-85-des-spondylarthropathies-aux-spondyloarthrites","status":"publish","type":"page","link":"http:\/\/www.smhp.fr\/?page_id=1042","title":{"rendered":"JFM 85. Des spondylarthropathies aux spondyloarthrites"},"content":{"rendered":"

Organis\u00e9e par les Pr Pascal Claudepierre et Dominique Lechevalier<\/strong><\/p>\n

Sous la pr\u00e9sidence du Professeur Jean-Pierre ALGAYRES
\nSecr\u00e9taires G\u00e9n\u00e9raux : Martine GAYRAUD et Jean-Marc ZIZA<\/p>\n

Programme d\u00e9finitif<\/strong><\/a><\/p>\n

Avec le soutien des laboratoires\u00a0Abbvie, Biobaran, MSD, Pfizer, UCB (ordre alphab\u00e9tique)<\/p>\n

\"AbbVieLogo\"<\/a>\u00a0 \u00a0\"Biogaran\"<\/a>\"msd\"<\/a><\/p>\n

\"Pfizer\"<\/a>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0\"UCB\"<\/a><\/p>\n

Introduction : la spondyloarthrite : quelques \u00ab mots \u00bb de terminologie<\/strong><\/a>
\nPascal Claudepierre, Cr\u00e9teil<\/p>\n

Intestin, microbiote et SpA<\/strong><\/a>
\nThierry Schaeverbeke, Bordeaux<\/p>\n

Evaluation de l\u2019activit\u00e9 de la maladie axiale : BASDAI ou ASDAS ?<\/strong><\/a>
\nC\u00e9dric Lukas, Montpellier<\/p>\n

Que repr\u00e9sentent les spondyloarthrites axiales non radiographiques ?<\/strong><\/a>
\nPascal Claudepierre, Cr\u00e9teil<\/p>\n

Radiographie et IRM dans le diagnostic des SpA axiales : avanc\u00e9es, limites et perspectives.
\nThao Pham, Marseille<\/p>\n

Les anti-TNF dans les spondyloarthrites axiales non radiographiques : r\u00e9sultats des essais et limites<\/strong><\/a>
\nPhilippe Goupille, Tours<\/p>\n

Les anti-TNF dans spondyloarthrites axiales dans la vraie vie : l\u2019exp\u00e9rience de la cohorte DESIR.
\nAnna Molto, Paris<\/p>\n

Echec d\u2019un anti-TNF dans les Spa axiales : CAT et perspectives \u00e0 court terme.
\nDaniel Wendling, Besan\u00e7on<\/p>\n","protected":false},"excerpt":{"rendered":"

Organis\u00e9e par les Pr Pascal Claudepierre et Dominique Lechevalier Sous la pr\u00e9sidence du Professeur Jean-Pierre ALGAYRES Secr\u00e9taires G\u00e9n\u00e9raux : Martine GAYRAUD et Jean-Marc ZIZA Programme d\u00e9finitif Avec le soutien des laboratoires\u00a0Abbvie, Biobaran, MSD, Pfizer, UCB (ordre alphab\u00e9tique) \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 Introduction : la spondyloarthrite : quelques \u00ab … Continuer la lecture de JFM 85. Des spondylarthropathies aux spondyloarthrites<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1021,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"http:\/\/www.smhp.fr\/index.php?rest_route=\/wp\/v2\/pages\/1042"}],"collection":[{"href":"http:\/\/www.smhp.fr\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.smhp.fr\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.smhp.fr\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.smhp.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1042"}],"version-history":[{"count":22,"href":"http:\/\/www.smhp.fr\/index.php?rest_route=\/wp\/v2\/pages\/1042\/revisions"}],"predecessor-version":[{"id":1112,"href":"http:\/\/www.smhp.fr\/index.php?rest_route=\/wp\/v2\/pages\/1042\/revisions\/1112"}],"up":[{"embeddable":true,"href":"http:\/\/www.smhp.fr\/index.php?rest_route=\/wp\/v2\/pages\/1021"}],"wp:attachment":[{"href":"http:\/\/www.smhp.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}